Vees et al. [25] described the role of F-18-choline and C-11-acetate in 20 patients with suspected residual or recurrent prostate cancer after radical prostatectomy with PSA levels <1 ng/ml. This evidence concerns the gene KLK3 and prostate carcinoma.